KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
67 hedge funds and large institutions have $148M invested in Kindred Biosciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
28
Reduced
16
Closed
7
Calls
$1K
Puts
$82K
Net Calls
-$81K
Net Calls Change
-$92K
Top Buyers
| 1 |
GAI
General American Investors
New York
|
+$5.23M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$4.71M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$2.97M |
| 4 |
PGC
Pacific Grove Capital
San Francisco,
California
|
+$1.48M |
| 5 |
BlackRock
New York
|
+$1.01M |
Top Sellers
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
-$1.44M |
| 2 |
Citigroup
New York
|
-$1.07M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$377K |
| 4 |
Millennium Management
New York
|
-$302K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$173K |
